0001209191-16-148752.txt : 20161107 0001209191-16-148752.hdr.sgml : 20161107 20161107193832 ACCESSION NUMBER: 0001209191-16-148752 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161104 FILED AS OF DATE: 20161107 DATE AS OF CHANGE: 20161107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHEID CENTRAL INDEX KEY: 0001037760 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 770441625 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 904 CARIBBEAN DRIVE CITY: SUNNYVALE STATE: CA ZIP: 94089 BUSINESS PHONE: 4085414191 MAIL ADDRESS: STREET 1: 904 CARIBBEAN DRIVE CITY: SUNNYVALE STATE: CA ZIP: 94089 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BISHOP JOHN L CENTRAL INDEX KEY: 0001189846 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30755 FILM NUMBER: 161979710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-04 1 0001037760 CEPHEID CPHD 0001189846 BISHOP JOHN L C/O CEPHEID 904 CARIBBEAN DRIVE SUNNYVALE CA 94089 1 1 0 0 Chairman of the Board and CEO Common Stock 2016-11-04 4 D 0 83092 D 0 D Restricted Stock Units 0.00 2016-11-04 4 D 0 9751 0.00 D Common Stock 9751 0 D Performance Stock Unit 0.00 2016-11-04 4 D 0 75000 0.00 D Common Stock 75000 0 D Employee Stock Option (Right to Buy) 20.47 2016-11-04 4 D 0 175000 0.00 D 2017-04-29 Common Stock 175000 0 D Employee Stock Option (Right to Buy) 31.485 2016-11-04 4 D 0 180000 0.00 D 2018-04-25 Common Stock 180000 0 D Employee Stock Option (Right to Buy) 35.72 2016-11-04 4 D 0 153750 0.00 D 2019-04-24 Common Stock 153750 0 D Employee Stock Option (Right to Buy) 38.66 2016-11-04 4 D 0 176250 0.00 D 2020-04-29 Common Stock 176250 0 D Employee Stock Option (Right to Buy) 45.84 2016-11-04 4 D 0 176250 0.00 D 2021-04-21 Common Stock 176250 0 D Employee Stock Option (Right to Buy) 56.88 2016-11-04 4 D 0 205000 0.00 D 2022-04-27 Common Stock 205000 0 D Employee Stock Option (Right to Buy) 35.94 2016-11-04 4 D 0 150000 0.00 D 2023-04-25 Common Stock 150000 0 D This number includes RSUs previously reported on Table I that at closing, were accelerated and converted into the right to receive $53 per share, without interest. On September 2, 2016, the Issuer entered into an Agreement and Plan of Merger ("Merger Agreement") with Danaher Corporation, a Delaware corporation (the "Acquirer"), and Copper Merger Sub, Inc., a California corporation and a wholly-owned subsidiary of the Acquirer. Upon the closing of the transactions contemplated by the Merger Agreement on November 4, 2016 (the "Closing"), each of the Reporting Person's shares of the Issuer's Common Stock was cancelled and converted into the right to receive $53 in cash, without interest (the "Merger Consideration"). Upon the Closing, 100% of the Reporting Person's unvested RSUs were accelerated and converted into the right to receive $53.00 per share, without interest. 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Upon the Closing, 100% of the Reporting Person's unvested PSUs were accelerated and converted into the right to receive $53.00 per share, without interest. The performance stock units will vest and be settled in shares of common stock based on the level of achievement of certain performance factors related to the company's revenue growth and operating margin over the three year performance period from January 1, 2016 to December 31, 2018. Depending on the level of performance, the number of shares of common stock delivered upon settlement can range from 0% to 125% of the target number represented above. Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Upon the Closing, this option was cancelled and ceased to exist without receiving any payment therefor. /s/ Jacobin Zorin, Attorney-In-Fact 2016-11-07